120 related articles for article (PubMed ID: 35800670)
1. Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination.
Kim HC; Yoon DY; Lee S; Jang IJ; Hong JH; Kim J
Transl Clin Pharmacol; 2022 Jun; 30(2):112-119. PubMed ID: 35800670
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the pharmacokinetics of a sustained-release formulation of a tramadol/acetaminophen combination in healthy subjects.
Im YJ; Jeon JY; Kim EY; Kim Y; Oh DJ; Yoo JS; Shin DH; Chae SW; Kim MG
Clin Ther; 2015 Feb; 37(2):376-89. PubMed ID: 25618318
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
Cho YS; Lee SH; Lim HS; Bae KS
J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
Yang E; Yoo H; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
[TBL] [Abstract][Full Text] [Related]
6. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects.
Hwang I; Park SI; Lee S; Lee B; Yu KS; Jeon JY; Kim MG
Transl Clin Pharmacol; 2018 Mar; 26(1):16-24. PubMed ID: 32055543
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
[TBL] [Abstract][Full Text] [Related]
13. Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
J Pain Res; 2015; 8():647-56. PubMed ID: 26508885
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.
Yang E; Lee S; Lee H; Hwang I; Jang IJ; Yu KS; Lee S
Transl Clin Pharmacol; 2019 Dec; 27(4):134-140. PubMed ID: 32095481
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
16. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
Lee JH; Lee CS;
Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection.
Szałek E; Karbownik A; Murawa D; Połom K; Urbaniak B; Grabowski T; Wolc A; Więckiewicz A; Grześkowiak E; Kokot ZJ; Murawa P; Burchardt P; Cieśla S
Pharmacol Rep; 2014 Feb; 66(1):159-64. PubMed ID: 24905322
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
Kim S; Ko JW; Kim JR
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
